Why don't cancer medicines work the same for everyone?
1 points, 0 comments on Hacker News
1 points, 0 comments on Hacker News
Parabilis Medicines Inc. , a clinical-stage cancer drug developer, raised nearly $745 million in an upsized US initial public offering that priced above its marketed range, and a private placement.